DBD DIEBOLD NIXDORF, Inc

BULLISH Impact: 5/10 Insider Cluster (5 insiders)
Horizon weeks Filed May 27, 2026 Processed 18d 13h ago
Insider cluster: 3 insiders, $0.2M total
Latest settled — T+5d ⚠ clustered
DBD ▲ +1.53% at T+5d
LONG call ✓ call won +1.53% · α vs SPY +1.21% · entry $81.04 → $82.28
Next anchor: T+20d in 10d
Last close $81.72 (close Jun 12) · +0.84% from $81.04 entry
Entry anchored
May 27, 2026
via day open
T+1d
+0.12%
call +0.12% · α -0.12%
$81.14
settled 18d ago
T+5d
+1.53%
call +1.53% · α +1.21%
$82.28
settled 12d ago
T+20d
call — · α —
in 10d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

A cluster of insider buying at Diebold Nixdorf, with CEO Octavio Marquez, CFO Thomas Timko, and Chief Revenue Officer Jonathan Myers making open-market purchases totaling ~$200K over several days. The CEO's two small purchases near $79.50 per share and the CRO's larger $100K purchase at $73.41 signal conviction in the stock near current levels.

Key Financial Metrics

Direction
buying
Total Value
$200.0K
Insiders
5

Actionable Insight

Despite the small dollar amount, this cluster carries genuine bullish signal — three top executives (CEO, CFO, CRO) all buying in the open market within a short window is rare and academically predictive. The CRO's purchase is the most notable at ~$100K. Historical calibration shows cluster-buy patterns on DBD have been modestly positive. Monitor for upcoming earnings or strategic announcements — this cluster suggests management sees the stock as undervalued. No cross-filing context signals distress.

Key Facts

  • CEO Marquez bought 1,250 shares total at ~$79.40-$79.56 for ~$99K over 2 days (May 26-27).
  • CFO Timko bought 672 shares at $74.36 on May 22 for ~$50K.
  • CRO Myers bought 1,360 shares at $73.41 on May 22 for $100K — the largest single purchase.
  • Total cluster open-market buys = ~$200K, representing ~0.007% of DBD's $2.8B market cap — very small proportionally.
  • Two directors received non-cash grant/awards of 2,621 shares each — no economic signal.

Financial Impact

$200K in insider purchases, trivial relative to $2.8B market cap (0.007%).

Risk Factors

  • The purchase amounts are very small relative to market cap and executive net worth — could be symbolic.
  • DBD's historical calibration shows negative average alpha at T+20 for this score band; past bullish reads did not consistently outperform.
  • No immediate catalyst identified — the buys may simply reflect routine 10b5-1 plan purchases.

Market Snapshot

Exchange
NYSE
Sector
Calculating & Accounting Machines (No Electronic Computers)
Analyst Consensus
86% bullish (7 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-DBD-1779915761815
4 reports for DBD
Performance horizon
Filters
Rows
Reports for DBD — sortable, filterable
Type Now
May 27, 2026
18d ago
Insider Cluster
BULLISH ★ 5/10
$81.04 $82.28▲ +1.53%▲ +1.21%$81.72 (+0.84%)
May 22, 2026
23d ago
Insider Cluster
NEUTRAL ★ 4/10
$79.43 $82.24▲ +3.54%▲ +2.33%$81.72 (+2.88%)
Mar 30, 2026
11w ago
Court Ruling
NEUTRAL ★ 3/10
$73.60 $78.25▲ +6.32%▲ +2.02%$81.72 (+11.03%)
Feb 25, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$83.05 $78.53▼ −5.44%▼ −4.32%$81.72 (−1.60%)
Showing 4 of 4

US Market Status

Market Closed — Opens in 2h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access